Atara Biotherapeutics, Inc. · NASDAQ:ATRA
Redmile Group, LLC exercised options for 195,211 Atara Biotherapeutics, Inc. shares (Form 4)
Traded Jul 22, 2026 · Filed Jul 24, 2026
On Jul 22, 2026, Redmile Group, LLC (Director) exercised options for 195,211 Atara Biotherapeutics, Inc. shares, leaving 636,852 shares. Filed Jul 24, 2026 (Form 4).
- Options exercised
- 195,211 shares
- Holding after
- 636,852 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | Common Stock | Option exercise | 195,211 | 636,912 | Indirect | |
| Jul 22, 2026 | Common Stock | Shares withheld for tax | 60 | 636,852 | Indirect |
Source
Related
- Atara Biotherapeutics, Inc.
- Redmile Group, LLC
- Atara Biotherapeutics, Inc. shareholders
- Form 4 · Cherry Brian N · Sep 4, 2026
- Form 4 · Nguyen AnhCo · Aug 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 24, 2026
- Form 4 · Cherry Brian N · Jun 15, 2026